NS5A resistance – associated substitutions in chronic hepatitis C patients with direct acting antiviral treatment failure in Turkey
Objectives: Chronic hepatitis C (CHC) is now a more curable disease with new direct acting antivirals (DAA). Although high sustained virologic response rates, failures still occur in DAA regimens. Our objective in this study was to characterize the real-life presence of clinically relevant resistanc...
Main Authors: | Murat Sayan, Figen Sarıgül Yıldırım, Sıla Akhan, Arzu Altunçekiç Yıldırım, Göktuğ Şirin, Mehmet Cabalak, Mehmet Demir, Selver Can, Gülden Ersöz, Engin Altıntaş, Fatih Ensaroğlu, Ayhan Akbulut, Alper Şener, Aydın Deveci |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220301946 |
Similar Items
-
Molecular Identification of HIV-1 in the Presence of Hepatitis B Virus and Hepatitis C Virus Co-infections
by: Müge Özgüler, et al.
Published: (2020-05-01) -
The sustained virologic response of nonresponder hepatitis C virus patients with retreatment
by: Sila Cetin Akhan, et al.
Published: (2011-01-01) -
Daclatasvir Plus Asunaprevir Dual Therapy for Chronic HCV Genotype 1b Infection: Results of Turkish Early Access Program
by: Seyfettin Köklü, et al.
Published: (2017-01-01) -
HBV and HCV Seroprevalence in Rheumatology Patients Using Biological Drugs
by: Mehmet Ali Balcı, et al.
Published: (2020-12-01) -
Evaluation of Response to Interferon Therapy in Chronic Hepatitis B and Chronic Hepatitis C Patients
by: Hakan LEBLEBİCİOĞLU, et al.
Published: (2001-09-01)